Gsk (GSK) Net Equity Issued and Repurchased (2009 - 2026)
Gsk (GSK) posted Net Equity Issued and Repurchased of $48.18 million for the quarter ended Dec 31, 2012, up 17.9% from $40.86 million a year earlier.
Powered by 
Analysis
Gsk (GSK) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2012, Gsk's Net Equity Issued and Repurchased came in at $91.93 million, up 27.4% from the prior year.
- Annual Net Equity Issued and Repurchased has increased for three consecutive years, with a three-year compound annual growth rate of 65.3% (years ended Dec 2009 to Dec 2012).
- In prior years, Gsk's Net Equity Issued and Repurchased was $72.16 million in the year ended Dec 31, 2011 (+174.5%), $26.28 million in the year ended Dec 31, 2010 (+29.1%) and $20.36 million in the year ended Dec 31, 2009.
- The figure for the quarter ended Dec 31, 2012 stands as the highest quarterly Net Equity Issued and Repurchased in data going back to the quarter ended Mar 31, 2009.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last four quarters, with growth averaging 188.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 1.20 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | - |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 450.29 Mn |
| Dec 31, 2025 | -421.66 Mn |
| Sep 30, 2025 | 2.46 Bn |
| Jun 30, 2025 | -1.26 Bn |
| Mar 31, 2025 | 326.21 Mn |
| Mar 31, 2024 | 22.83 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Mar 31, 2023 | 9.72 Mn |
| Mar 31, 2022 | 22.81 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Mar 31, 2021 | 20.68 Mn |
| Dec 31, 2020 | 1.32 Mn |
| Mar 31, 2020 | 29.48 Mn |
| Dec 31, 2019 | 12.86 Mn |
| Sep 30, 2019 | 9.87 Mn |
| Mar 31, 2019 | 35.15 Mn |
| Dec 31, 2018 | 55.33 Mn |
| Mar 31, 2018 | 15.30 Mn |
| Dec 31, 2017 | 10.62 Mn |
| Mar 31, 2017 | 39.64 Mn |
API Access
Gsk Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();